Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.
Professor Samira Lakhal-Littleton from the Department of Physiology, Anatomy and Genetics is part of a team of international collaborators awarded 15 million euros, including 2.6 million euros to Oxford, from the European Research Council.
Researchers from the Department of Oncology are part of a \u20ac50 million European project looking at how innovative medical and digital technologies can improve the early detection of heart-related problems in cancer patients and survivors.
A new study led by researchers at the University of Oxford demonstrates that the huge success of effective antiretroviral therapy (ART) against HIV could have altered the course of human evolution.
New data published today in the European Society for Medical Oncology (ESMO) Real World Data and Digital Oncology show that more than half of people receiving systemic anticancer treatment had a history of obesity, compared with only around one in four who were classified as obese at the time their treatment began.
The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), a Cyrus Poonawalla group company and the world\u2019s largest vaccine manufacturer by volume, have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.
Oxford University researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson\u2019s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.
Malaria is one of the world\u2019s oldest known diseases, but it is a modern disease too - it continues to kill roughly 600,000 people each year. Most of these people are children, living in Sub-Saharan Africa.
A major international study led by researchers at the Nuffield Dept of Women's & Reproductive Health, University of Oxford has found that lowering blood pressure reduces the risk of cardiovascular disease by approximately 9\u201310% for every 5 mm Hg reduction in systolic blood pressure with consistent benefits across all stages of chronic kidney disease (CKD).
The PANORAMIC trial, led from Oxford's Nuffield Department of Primary Care Health Sciences, finds that Paxlovid speeds COVID-19 recovery but does not reduce hospitalisations or deaths in vaccinated higher-risk adults. Published alongside Canada's CanTreatCOVID trial in the New England Journal of Medicine.
Despite the NHS adding roughly 250,000 staff between 2018 and 2023, elective surgery waiting lists kept growing. New research analysing 132 NHS Trusts finds that staff sickness absence and unstable administrative teams \u2013 not workforce size \u2013 are key factors.
New data reveals that 104 children in England have died between April 2019 and 3 December 2024 with temporary accommodation identified as a contributing factor to their vulnerability, ill health or death.
Associate Professor Lisa Heather, from the Department of Physiology, Anatomy and Genetics (DPAG), has been awarded an International Cardiovascular Research Partnership Award (ICRPA). The ICRPA scheme supports high-quality international research collaborations that have the potential to accelerate progress towards improved understanding, prevention, diagnosis and treatment of cardiovascular disease.
Professor Asifa Majid of the Department of Experimental Psychology has been awarded the prestigious Humboldt Research Award by the Alexander von Humboldt Foundation.
To mark 2026 International Women\u2019s Day, the NDCN Women in Clinical Neurosciences (WICN) committee organised a series of informative and inspiring talks on 6 March, with the focus on empowering career progression for all at the Nuffield Department of Clinical Neurosciences (NDCN).
Most children with a severely broken wrist can be treated without surgery, according to a major NIHR-funded UK trial led by researchers at the University of Oxford. The findings suggest that a non-surgical, cast-first approach delivers similar long-term recovery while reducing the risks associated with surgery and costs.
The Chair of the COVID-19 Inquiry has described the RECOVERY trial\u2019s identification of the drug dexamethasone as \u2018one of the two success stories of the pandemic\u2019.
A new EPSRC-funded research project led by Dr Kristoffer Petersson from the Department of Oncology aims to advance the clinical implementation of FLASH radiotherapy, an emerging technique that delivers radiation in a fraction of a second and may significantly reduce treatment side effects.
A simple low-cost change to workplace cafeteria menus can significantly increase vegetarian meal sales, reducing the environmental impact and calorie content of food sold, according to a new trial from the Nuffield Department of Primary Care Health Sciences, University of Oxford.
New study shows that a balance between cooperation and competition is a fundamental principle of how human and animal brains function, a finding which could help inform more realistic brain-like artificial intelligence, such as digital twin brains.
![\"Enzyme](\"https://www.medsci.ox.ac.uk/news/research-uncovers-new-mechanism-controlling-inflammation-in-immune-cells/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n